Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Roflumilast in Hospitalized COPD on Mortality and Re-hospitalization

NCT01973998 is registered in ClinicalTrials.gov with Temple University as lead sponsor.

NCT NCT01973998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01973998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Roflumilast in Hospitalized COPD on Mortality and Re-hospitalization
Lead sponsor
Temple University
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2013
Completion date
November 30, 2017
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd